Right Hepatic Lobe Lesions
Conditions
Interventions
Sponsors
Aichi Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adequate major organ function (bone marrow, cardiac, hepatic, pulmonary, and renal function) is preserved. 2) Patients with a performance status suitable for endoscopy: ECOG Performance Status 0, 1, or 2. 3) Patients expected to survive for at least 4 weeks. 4) Written informed consent has been obtained from the patient.
Exclusion criteria
Exclusion criteria: 1) Patients with a history of surgical resection of the right hepatic lobe. 2) Patients at high risk of bleeding: Platelet count < 50,000 PT-INR >= 1.5 APTT >= 1.5 times the upper limit of normal 3) Patients with gastrointestinal stenosis. 4) Patients with massive ascites in whom a safe puncture route cannot be secured. 5) Patients with active infection or uncontrolled cholangitis or sepsis. 6) Patients in whom the operator judges that lesion visualization or a safe puncture route cannot be achieved by EUS. 7) Patients deemed inappropriate for this study by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic accuracy of EUS-FNA in each right hepatic segment (S5, S6, S7, and S8) | — |
Secondary
| Measure | Time frame |
|---|---|
| Visualization rate, puncture success rate, and adverse events of EUS-FNA in each right hepatic segment (S5, S6, S7, and S8) | — |
Countries
Japan
Contacts
Public ContactNozomi Okuno
Aichi Cancer Center Department of Gastroenterology
Outcome results
None listed